biostudies-literatureUnknown7(10)Kostuj T<h4>Objective</h4>Most patients suffering with rheumatic diseases who undergo surgical treatment are receiving immune-modulating therapy. To determine whether these medications affect their outcomes a national registry was established in Germany by the German Society of Surgery (DGORh). Data from the first 1000 patients were used in a pilot study to identify relevant corisk factors and to determine whether such a registry is suitable for developing accurate and relevant recommendations.<h4>Design and participants</h4>Data were collected from patients undergoing surgical treatments with their written consent. A second consent form was used, if complications occurred. During this pilot study, in order to obtain a quicker overview, risk factors were considered only in patients with complicatiBMJ opene015987https://www.ebi.ac.uk/biostudies/studies/S-EPMC5640080biostudies-literaturePilot study for the registry of complications in rheumatic diseases from the German Society of Surgery (DGORh): evaluation of methods and data from the first 1000 patients.PMC5640080Matta-Hurtado Rstudy group “complication-register of the DGORh”Willburger RERehart SKostuj TSchmidt KBiehl CfalsePilot study for the registry of complications in rheumatic diseases from the German Society of Surgery (DGORh): evaluation of methods and data from the first 1000 patients.<h4>Objective</h4>Most patients suffering with rheumatic diseases who undergo surgical treatment are receiving immune-modulating therapy. To determine whether these medications affect their outcomes a national registry was established in Germany by the German Society of Surgery (DGORh). Data from the first 1000 patients were used in a pilot study to identify relevant corisk factors and to determine whether such a registry is suitable for developing accurate and relevant recommendations.<h4>Design and participants</h4>Data were collected from patients undergoing surgical treatments with their written consent. A second consent form was used, if complications occurred. During this pilot study, in order to obtain a quicker overview, risk factors were considered only in patients with complicati2017-01-01T00:00:00Z2017 Oct2025-04-18T19:04:37.908Z2019-03-26T22:45:48ZS-EPMC56400802901806610.1136/bmjopen-2017-015987